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      Abstract 
Background: Recently, SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 
2) identified and classified as a single stranded (positive sense) RNA virus causes COVID-
19 (Coronavirus disease 2019). It was first detected in China. Symptoms of the disease 
include severe acute respiratory syndrome. The disease has become pandemic affecting 
the globe. No vaccine has been discovered to be of impact in the control of this deadly 
disease. MERS-CoV (Middle East Respiratory Syndrome Coronavirus) recognizes DPP4 
(dipeptidyl peptidase 4) as its receptor. ACE2 (Angiotensin-Converting Enzyme 2) is a 
receptor for SARS-CoV. COVID-19 is zoonotic, probably of feline origin or from bats. In 
the United States, hydroxychloroquine sulphate and zinc in combination with the 
antibiotic azithromycin or doxycyline is currently under clinical trial and being 
investigated as a possible potential therapy for COVID-19. Investigation: Presently, in 
Nigeria, West Africa, infection with SARS-CoV-2 is being managed with seemingly 
minimal mortality. In this investigation, the alcohol extract of a combination of Garcinia 
kola seeds and Zingiber officinale leaves, with medicinal value, used locally in some 




COVID-19 (Coronavirus disease 2019) is an infectious disease caused by the Severe 
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The disease was first 
identified in December 2019 in Wuhan, the capital of China's Hubei province, and has 
since spread globally. The virus is probably of feline origin or from bats (Wikipedia, 
2020a). MERS-CoV (Middle East Respiratory Syndrome Coronavirus) seems to have 
originated from bats but transmitted to humans through camels (Wikipedia, 2020c). No 
prophylactic drug or vaccine has been developed or discovered for COVID-19 (WHO, 
2020).  
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Nigeria, West Africa, is a developing country that depends on developed countries 
like Australia, Britain, the United States and Canada for the detection of disease causing 
microbial agents; the use of prophylactic drugs; and even vaccines in the management 
and control of infections and diseases. We herein present a statistical epidemiological 
update on recent cases of infection with Severe Acute Respiratory Syndrome Coronavirus 
2 (SARS-CoV-2) in Nigeria. An alcohol extract of a combination of Garcinia kola seeds and 
Zingiber officinale leaves is being reported in this investigation as a potential control 
therapy. 
Materials and Methods 
Study Population 
 The study population spanned individuals of all age ranges in all the thirty six 
States and Abuja the Federal Capital Territory of Nigeria, West Africa. 
Collection of Oropharyngeal Samples 
 Oropharyngeal samples were collected from patients presenting symptoms of 
COVID-19. The samples were immediately presented for assay of SARS-Cov-2 using the 
Primerdesign COVID-19 detection method. 
SARS-Cov-2 Assay Method 
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was detected 
using the Primerdesign Ltd COVID-19 genesig® Real-Time PCR assay method 
(Primerdesign, 2020). 
The Primerdesign Ltd COVID-19 genesig® Real-Time PCR assay is a real-time RT-PCR 
assay intended for the qualitative detection of nucleic acid from SARS-CoV-2 in 
oropharyngeal swab specimens from patients suspected of COVID-19. It is a molecular 
in vitro diagnostic test for the detection of the SARS-CoV-2 RNA in oropharyngeal swab 
specimens from patients suspected of COVID-19 by their healthcare provider. It aids the 
diagnosis of coronavirus COVID-19 disease. The assay is based on widely used nucleic 
acid amplification technology. The product contains oligonucleotide primers and dual-
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labeled hydrolysis probes, as well as control material, for the use in reverse transcriptase 
Real-Time-PCR for the in vitro qualitative detection of SARS-CoV-2 RNA in 
oropharyngeal swab specimens. 
Oropharyngeal swab samples were carefully taken from patients who showed symptoms 
of and suspected of COVID-19. 
Collection of Plant Samples 
Fresh leaves of Zingiber officinale were collected around the University College 
Hospital (UCH), Ibadan, Nigeria environ. They were identified in the Herbarium of the 
Department of Botany, University of Ibadan, Ibadan, Nigeria by Professor Taiye R. Fasola 
of the same department. Garcinia kola seeds were bought at Oje Market, Ibadan, Nigeria. 
They were also identified by Professor Taiye R. Fasola.  The fresh Zingiber officinale leaves 
and Garcinia kola seeds were stored in air-tight containers for analysis. 
Extraction 
 A combination of 180g of fresh Zingiber officinale leaves and 200g of fresh Garcinia 
kola seeds were ground and soaked in 1Litre of absolute alcohol and left overnight for 
four days. The extract was filtered and concentrated to about one-sixth of its original 
volume in vacuo using a rotary evaporator (Quick fit, Rotavapor-R, Buchi, Switzerland) 
at 30oC under low vacuum pressure and low evaporation. 
Anti-SARS-Cov-2 Activity  
 Fifty (50) human subjects diagnosed positive for SARS-COV-2 participated in this 
research study. Ethical approval was obtained from the University College Hospital 
Research Committee. 100ml of extract was given orally to the human subjects before meal 
on a daily basis for a period of six days. Thereafter, their oropharyngeal samples were 
collected and assayed for the presence of SARS-Cov-2.  
Results 
Statistical data from the Nigerian Centre for Disease Control (NCDC) is presented 
in Table 1. 
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Table 1: Statistical data from the Nigerian Centre for Disease Control (NCDC) 
evaluating the recent epidemiological significance of COVID-19 and infection with 
SARS-CoV-2 in Nigeria 
COVID-19 Update  
Case Summary in Nigeria as of 13th April, 2020  
Total Sample Tested = 1,0918  
Total Confirmed Cases = 1,273  
Total Active Cases = 994  
Discharged = 239  
Deaths = 40  
Lagos                                                                      
Number of Cases (Laboratory Confirmed): 731   
Number of Active Cases: 584                               
Number Discharged: 128                                       
Number of Deaths: 19 
 
Abuja FCT                                                                    
Number of Cases (Laboratory Confirmed):141     
Number of Active Cases: 103                                
Number Discharged: 35                                         
Number of Deaths: 3 
 
Kano                                                                       
Number of Cases (Laboratory Confirmed): 77     
Number of Active Cases: 76                                 
Number Discharged: 0                                          
Number of Deaths: 1 
 
Ogun                                                                      
Number of Cases (Laboratory Confirmed): 35     
Number of Active Cases: 29                                 
Number Discharged: 5                                          
Number of Deaths: 1 
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Gombe                                                                    
Number of Cases (Laboratory Confirmed): 35       
Number of Active Cases: 35                                  
Number Discharged: 0                                           
Number of Deaths: 0 
 
Osun                                                                       
Number of Cases (Laboratory Confirmed): 34       
Number of Active Cases: 14                                  
Number Discharged: 18                                        
Number of Deaths: 2 
 
Katsina                                                                    
Number of Cases (Laboratory Confirmed): 30       
Number of Active Cases: 24                                  
Number Discharged: 4                                           
Number of Deaths: 2 
 
Borno                                                                    
Number of Cases (Laboratory Confirmed): 30       
Number of Active Cases: 28                                  
Number Discharged: 0                                           
Number of Deaths: 2 
 
Edo                                                                        
Number of Cases (Laboratory Confirmed): 25       
Number of Active Cases: 14                                  
Number Discharged: 8                                           
Number of Deaths: 3 
 
Oyo                                                                        
Number of Cases (Laboratory Confirmed): 21       
Number of Active Cases: 10                                  
Number Discharged: 9                                           
Number of Deaths: 2 
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Akwa Ibom                                                                        
Number of Cases (Laboratory Confirmed): 12       
Number of Active Cases: 2                                    
Number Discharged: 9                                           
Number of Deaths: 1 
 
Kaduna                                                                        
Number of Cases (Laboratory Confirmed): 15       
Number of Active Cases: 9                                   
Number Discharged: 6                                           
Number of Deaths: 0 
 
Bauchi                                                                        
Number of Cases (Laboratory Confirmed): 14       
Number of Active Cases: 8                                   
Number Discharged: 6                                           
Number of Deaths: 0 
 
Kwara                                                                        
Number of Cases (Laboratory Confirmed): 11       
Number of Active Cases: 9                                   
Number Discharged: 2                                           
Number of Deaths: 0 
 
Sokoto                                                                        
Number of Cases (Laboratory Confirmed): 10       
Number of Active Cases: 10                                  
Number Discharged: 0                                           
Number of Deaths: 0 
 
Ekiti                                                                        
Number of Cases (Laboratory Confirmed): 8       
Number of Active Cases: 5                                   
Number Discharged: 2                                           
Number of Deaths: 1 
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Ondo                                                                        
Number of Cases (Laboratory Confirmed): 8       
Number of Active Cases: 6                                   
Number Discharged: 2                                           
Number of Deaths: 0 
 
Delta                                                                        
Number of Cases (Laboratory Confirmed): 6       
Number of Active Cases: 5                                   
Number Discharged: 0                                           
Number of Deaths: 1 
 
Rivers                                                                        
Number of Cases (Laboratory Confirmed): 6       
Number of Active Cases: 2                                   
Number Discharged: 2                                           
Number of Deaths: 2 
 
Taraba                                                                        
Number of Cases (Laboratory Confirmed): 6       
Number of Active Cases: 6                                   
Number Discharged: 0                                           
Number of Deaths: 0 
 
Abia                                                                        
Number of Cases (Laboratory Confirmed): 2       
Number of Active Cases: 2                                   
Number Discharged: 0                                           
Number of Deaths: 0 
 
Enugu                                                                        
Number of Cases (Laboratory Confirmed): 2       
Number of Active Cases: 0                                   
Number Discharged: 2                                           
Number of Deaths: 0 
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Niger                                                                        
Number of Cases (Laboratory Confirmed): 2       
Number of Active Cases: 2                                   
Number Discharged: 0                                           
Number of Deaths: 0 
 
Jigawa                                                                        
Number of Cases (Laboratory Confirmed): 2       
Number of Active Cases: 2                                   
Number Discharged: 0                                           
Number of Deaths: 0 
 
Zamfara                                                                        
Number of Cases (Laboratory Confirmed): 2       
Number of Active Cases: 2                                   
Number Discharged: 0                                           
Number of Deaths: 0 
 
Benue                                                                        
Number of Cases (Laboratory Confirmed): 1       
Number of Active Cases: 1                                   
Number Discharged: 0                                           
Number of Deaths: 0 
 
Anambra                                                                        
Number of Cases (Laboratory Confirmed): 1       
Number of Active Cases: 0                                   
Number Discharged: 1                                           
Number of Deaths: 0 
 
Adamawa                                                                        
Number of Cases (Laboratory Confirmed): 1       
Number of Active Cases: 0                                   
Number Discharged: 1                                           
Number of Deaths: 0 
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Plateau                                                                        
Number of Cases (Laboratory Confirmed): 1       
Number of Active Cases: 1                                   
Number Discharged: 0                                           
Number of Deaths: 0 
 
Imo                                                                        
Number of Cases (Laboratory Confirmed): 1       
Number of Active Cases: 1                                   
Number Discharged: 0                                           
Number of Deaths: 0 
 
Bayelsa                                                                        
Number of Cases (Laboratory Confirmed): 1       
Number of Active Cases: 1                                   
Number Discharged: 0                                           
Number of Deaths: 0 
 
Ebonyi                                                                        
Number of Cases (Laboratory Confirmed): 1       
Number of Active Cases: 1                                   
Number Discharged: 0                                           
Number of Deaths: 0 
 
Kebbi                                                                        
Number of Cases (Laboratory Confirmed): 1       
Number of Active Cases: 1                                   
Number Discharged: 0                                           
Number of Deaths: 0 
 
 
As of 13th April, 2020, samples from a total of 1,0918 individuals were tested for 
SARS-CoV-2 in Nigeria according to the Nigerian Centre for Disease Control (NCDC). 
Samples from 1,273 individuals were confirmed positive for SARS-CoV-2. 994 
individuals presented with COVID-19. Of the 1,0918 individuals, mortality was 40 (Table 
1).  
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Of all the fifty (50) human subjects (diagnosed positive for SARS-CoV-2) who 
participated in this research study, after the administration of the plants’ extract for the 
period of six days, none tested positive for SARS-CoV-2 using the Primerdesign test kit. 
Also none presented symptoms of COVID-19. 
Discussion  
 COVID-19 which is presently pandemic was first detected in Nigeria in Lagos on 
the 27th of February, 2020 (NCDC, 2020). The disease has since become endemic in Nigeria 
(Wikipedia, 2020b). Till date, no vaccine has been developed to stem this menace. 
Hydrochloroquine sulphate and zinc in combination with the antibiotic azithromycin or 
doxycycline is presently under clinical trial in United States of America as a potential 
therapy for SARS-CoV-2 infection (US NIH, 2020).  In Nigeria, plants including herbs and 
shrubs with medicinal values are used in the treatment of various ailments (Adejuwon 
and Tsygankova, 2019). In this present investigation, the alcohol extract of a combination 
of the seeds of Garcinia kola and leaves of Zingiber officinale were observed to seemingly 
have anti-SARS-CoV-2 inhibitory potential. In light of the existence of the present 
pandemic, COVID-19 caused by the viral strain SARS-CoV-2, the bioactive constituents 
of the alcohol extract of a combination of the seeds of Garcinia kola and leaves of Zingiber 
officinale should be investigated for a possible vaccine development or prophylactic 
therapeutic application.   
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